TuHURA Biosciences, Inc.
HURA
$3.25
$0.3411.68%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -80.88% | -37.63% | -123.55% | -- | |
| Total Depreciation and Amortization | -62.36% | -58.89% | -51.11% | -- | |
| Total Amortization of Deferred Charges | -- | -- | 3,260.78% | -- | |
| Total Other Non-Cash Items | 125.99% | 341.77% | 893.83% | -- | |
| Change in Net Operating Assets | 310.93% | -23.12% | 527.20% | -- | |
| Cash from Operations | -23.34% | -23.58% | 14.22% | -- | |
| Capital Expenditure | 84.66% | -- | 46.10% | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -- | |
| Cash from Investing | -328.77% | -- | -1,974.31% | -- | |
| Total Debt Issued | -- | -- | -100.00% | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 27.33% | -83.62% | -- | -- | |
| Cash from Financing | -32.85% | -111.83% | -230.94% | -- | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -70.79% | -908.20% | -1,701.82% | -- | |